PIERIS PHARMACEUTICALS, INC.·4

Dec 9, 7:32 AM ET

KIRITSY CHRISTOPHER P 4

4 · PIERIS PHARMACEUTICALS, INC. · Filed Dec 9, 2024

Insider Transaction Report

Form 4
Period: 2024-12-02
Transactions
  • Award

    Stock Option (right to buy)

    2024-12-02+500500 total
    Exercise: $16.43Exp: 2034-12-02Common Stock (500 underlying)
Footnotes (1)
  • [F1]The stock option will vest as to 100% of the underlying shares on December 2, 2025, subject to the Reporting Person's continued service as a director through the vesting date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4 (ANNUAL GRANT)